Form 4: Zomedica Corp. Director Rodney Williams Reports Acquisition of 100,000 Shares
SEC Form 4 Filing
Director Rodney Williams reports purchasing 100,000 shares of Zomedica Corp. common stock at $0.069 per share.
Summary
- On March 17, 2025, Rodney Williams, a director of Zomedica Corp., acquired 100,000 shares of common stock.
- The purchase price was $0.069 per share.
- Following the transaction, Mr. Williams directly owns 100,000 shares.
- He also indirectly owns 40,000 shares through Entrust Group f/b/o Rodney J. Williams IRA.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the amount is not substantial enough to significantly impact sentiment.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider trading. It's common for directors and officers to buy or sell shares of their own company, and these transactions are closely monitored by regulators and investors.
Stakeholder Impact
- The purchase could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of transaction: Rodney Williams acquired 100,000 shares of Zomedica Corp. common stock. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.